Vallon Pharmaceuticals Inc. (VLON:NASDAQ) rocketted at $0.52, representing a gain of 104.7%. On Wed, Dec 14, 2022, VLON:NASDAQ hit a New 2-Week High of $0.52. The stock appeared on our News Catalysts scanner on Tue, Dec 13, 2022 at 04:37 PM in the 'AGREEMENT' category. From Wed, Nov 30, 2022, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Dec 14, 2022 at $0.79 with a volume of 98M+.
About Vallon Pharmaceuticals Inc. (VLON:NASDAQ)
Vallon Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development and commercialization of proprietary biopharmaceutical products.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Icosavax Inc. (ICVX:NASDAQ), 112.38%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 104.69%
- Core Scientific Inc Cl A (CORZ:NASDAQ), 69.72%
- Avidity Biosciences Inc. (RNA:NASDAQ), 55.28%
- Shineco Inc. (SISI:NASDAQ), 44.85%
- Meiwu Technology Company Limited (WNW:NASDAQ), 41.3%
- BOQI International Medical Inc. (BIMI:NASDAQ), 36.06%
- Nuvve Holding Corp. (NVVE:NASDAQ), 32.34%
- Inspira Technologies Oxy B.H.N. Ltd. (IINN:NASDAQ), 30.95%